June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Yüksel Ürün: Denosumab every 12 weeks vs. every 4 weeks in mCRPC
Feb 18, 2025, 15:11

Yüksel Ürün: Denosumab every 12 weeks vs. every 4 weeks in mCRPC

Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared a post on X:

“Denosumab every 12 weeks vs. every 4 weeks in mCRPC:

Lower risk of ONJ and tooth infections with q12w dosing.

Favorable long-term safety profile.

Could q12w become the new standard?”

Yüksel Ürün: Denosumab every 12 weeks vs. every 4 weeks in mCRPC

More posts featuring Yüksel Ürün.